Case Study: Addex Therapeutics accelerates CNS drug discovery with Dotmatics

Addex Therapeutics saves scientists hours analyzing data with Dotmatics

Addex Therapeutics, a biotech company developing small molecule drugs for central nervous system diseases, faced challenges with an outdated platform, poor data management, and significant time wasted analyzing data. To accelerate innovation, they sought a better R&D data management solution and turned to Dotmatics, implementing the Dotmatics platform.

By centralizing and analyzing their data with the Dotmatics platform, Addex modernized their systems and established manageable data flows. Dotmatics delivered substantial time savings, with the company's Head of IT noting that the integration saves scientists hours of data analysis time compared to their previous solution.

Addex Therapeutics